14 articles for S Yoon
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template.

Seoul National University
2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Seoul National University
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Seoul National University
6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists.

Shenyang Pharmaceutical University
Design and synthesis of protein kinase C epsilon selective diacylglycerol lactones (DAG-lactones).

Seoul National University
Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.

Seoul National University
Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.

Sookmyung Women'S University
1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPAR¿ partial agonists.

Sookmyung Women'S University
Structure-Activity Relationships of Truncated 1'-Homologated Carbaadenosine Derivatives as New PPARγ/δ Ligands: A Study on Sugar Puckering Affecting Binding to PPARs.

Seoul National University
2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists.

Seoul National University
Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors.

Seoul National University
Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist.

Sk Chemicals
Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.

Pusan National University
Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.

Seoul National University